Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients - evaluation of appropriate research design and methodology to measure symptoms

@article{Matsuda2005MildCI,
  title={Mild cognitive impairment after adjuvant chemotherapy in breast cancer patients - evaluation of appropriate research design and methodology to measure symptoms},
  author={Tomohiro Matsuda and T. Takayama and M. Tashiro and Y. Nakamura and Y. Ohashi and K. Shimozuma},
  journal={Breast Cancer},
  year={2005},
  volume={12},
  pages={279-287}
}
  • Tomohiro Matsuda, T. Takayama, +3 authors K. Shimozuma
  • Published 2005
  • Medicine
  • Breast Cancer
  • The development of new chemotherapeutic agents and regimens has contributed to reduced risk of cancer recurrence and prolonged patient survival. However, mild cognitive impairment (MCI), also known as “chemofog” or “chemobrain” following adjuvant chemotherapy for breast cancer has been reported since the late 1980s. Unfortunately, little is known about it's mechanism, type, severity, and episode length. This article reviewed related studies on the subject, and found that chemotherapy-induced… CONTINUE READING
    93 Citations

    Paper Mentions

    Observational Clinical Trial
    The main purpose of this study is to build upon the evidence captured in the Imaging Dementia - Evidence for Amyloid Scanning (IDEAS; NCT02420756) trial to include valuable information… Expand
    ConditionsAlzheimer's Disease, Dementia, Mild Cognitive Impairment
    Observational Clinical Trial
    The main purpose of this study is to explore the impact of an amyloid positron emission tomography and computed tomography (PET/CT) scan on physician diagnosis and management… Expand
    ConditionsAlzheimer's Disease, Dementia, Mild Cognitive Impairment
    InterventionDrug
    Interventional Clinical Trial
    Chemobrain is an expression used to describe a cluster of chemotherapy-induced cognitive impairment symptoms, including problems with visual and verbal memory, forgetfulness… Expand
    ConditionsBreast Cancer, Chemo-brain, Drug-Related Side Effects and Adverse Reactions, (+1 more)
    InterventionDrug, Procedure
    Adjuvant Chemotherapy for Breast Cancer and Cognitive Impairment
    • 17
    [A meta-analysis of chemotherapy related cognitive impairment in patients with breast cancer].
    • 9
    • Highly Influenced
    • PDF
    Cognitive function after chemotherapy in adults with solid tumours.
    • 178
    Neuro-cognitive impairment in breast cancer patients: pharmacological considerations.
    • 40
    Cognitive function in breast cancer survivors.
    • J. Vardy
    • Medicine
    • Cancer treatment and research
    • 2009
    • 66

    References

    SHOWING 1-10 OF 58 REFERENCES
    Late effects of adjuvant chemotherapy on cognitive function: a follow-up study in breast cancer patients.
    • 235
    Breast cancer chemotherapy-related cognitive dysfunction.
    • 157
    Cognitive dysfunction following adjuvant treatment of breast cancer: a new dose-limiting toxic effect?
    • P. Ganz
    • Medicine
    • Journal of the National Cancer Institute
    • 1998
    • 54
    • PDF
    Cognitive function, fatigue, and menopausal symptoms in women receiving adjuvant chemotherapy for breast cancer.
    • N. Tchen, H. G. Juffs, +9 authors I. Tannock
    • Medicine
    • Journal of clinical oncology : official journal of the American Society of Clinical Oncology
    • 2003
    • 359
    Cognitive Effects of Standard-Dose Chemotherapy in Patients with Cancer
    • 190